Literature DB >> 8530693

Immunohistochemical localization, identification and regulation of the interleukin-1 receptor antagonist in the human endometrium.

C Simón1, A Frances, B Y Lee, A Mercader, T Huynh, J Remohi, M L Polan, A Pellicer.   

Abstract

There is evidence suggesting the importance of the interleukin-1 receptor type I (IL-1Rtl) and interleukin-1 beta (IL-1 beta) as mediator in local intercellular interactions in endometrial tissue and embryonic implantation. To complete our understanding of the entire endometrial IL-1 system in humans, we have investigated the immunohistochemical distribution of IL-1 receptor antagonist (IL-1ra) in the human endometrium throughout the menstrual cycle. We have also identified the forms of IL-1ra present in human endometrial cells. Immunoreactive IL-1ra was found in both cryostat and paraffin-embedded sections of human endometrium using the alkaline phosphatase-peroxidase (A-P) method with two different IL-1ra antibodies. IL-1ra was present throughout the entire menstrual cycle, located primarily in the endometrial epithelium. However, IL-1ra staining was significantly higher during follicular phase in comparison with early and mid-late luteal phases. Reverse transcriptase polymerase chain reaction of cultured stromal and glandular cells showed that these cells express the intracellular form of IL-1ra mRNA (icIL-1ra). Our results demonstrate the regulated presence of the icIL-1ra in the human endometrium. This finding supports a possible autocrine-paracrine role for the IL-1 system in the human endometrium and embryonic implantation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530693     DOI: 10.1093/oxfordjournals.humrep.a136326

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia.

Authors:  Charles J Lockwood; Paul Matta; Graciela Krikun; Louise A Koopman; Rachel Masch; Paolo Toti; Felice Arcuri; Se-Te Joseph Huang; Edmund F Funai; Frederick Schatz
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

Authors:  Mamadou Keita; Paul Bessette; Manuella Pelmus; Youssef Ainmelk; Aziz Aris
Journal:  J Ovarian Res       Date:  2010-01-28       Impact factor: 4.234

3.  The implication of aberrant GM-CSF expression in decidual cells in the pathogenesis of preeclampsia.

Authors:  S Joseph Huang; Ana C Zenclussen; Chie-Pein Chen; Murat Basar; Hui Yang; Felice Arcuri; Min Li; Erdogan Kocamaz; Lynn Buchwalder; Mizanur Rahman; Umit Kayisli; Frederick Schatz; Paolo Toti; Charles J Lockwood
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

4.  Leptin upregulates beta3-integrin expression and interleukin-1beta, upregulates leptin and leptin receptor expression in human endometrial epithelial cell cultures.

Authors:  R R Gonzalez; P Leavis
Journal:  Endocrine       Date:  2001-10       Impact factor: 3.633

5.  Immunopathology of early pregnancy.

Authors:  G Chaouat; E Menu; B Mognetti; M Moussa; V Cayol; Y Mostefaoui; S Dubanchet; P Khadel; J L Voluménie; C B Rongiéres; G L Delage
Journal:  Infect Dis Obstet Gynecol       Date:  1997

6.  Early Mid-pregnancy Blood-Based Proteins as Possible Biomarkers of Increased Infant Birth Size in Sex-Stratified Analyses.

Authors:  Emelie Lindberger; Fredrik Ahlsson; Katja Junus; Theodora Kunovac Kallak; Susanne Lager; Paliz Nordlöf Callbo; Anna-Karin Wikström; Inger Sundström Poromaa
Journal:  Reprod Sci       Date:  2022-09-30       Impact factor: 2.924

7.  Development of a xeno-free non-contact co-culture system for derivation and maintenance of embryonic stem cells using a novel human endometrial cell line.

Authors:  Nina Desai; Jennifer Ludgin; Jeffrey Goldberg; Tommaso Falcone
Journal:  J Assist Reprod Genet       Date:  2013-04-11       Impact factor: 3.412

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.